New classification criteria for spondyloarthritis cover a wide spectrum of patients.
Men are more likely to stay the course of TNF inhibitor therapy.
A bio-psychosocial approach geared to the patient’s specific needs, preferences, priorities, and pain characteristics.
Updates from the 2018 British Society for Rheumatology conference focus on RA treatment targets and resistance to biologics.
Smoking, obesity, RF and anti-CCP positivity, high disease activity, early erosions—one of these was found to protect against severe joint damage.
What’s new: advances in serodiagnostic testing, role of T cell activation in Lyme arthritis, and post-treatment Lyme disease syndrome.
Consider screening patients with RA for HBV exposure/infection as a part of the pretreatment assessment.
Recommendations from the US Preventive Services Task Force that seem counterintuitive.
Your patient is a young woman who presents with a facial rash, joint pain, and fatigue. How will you proceed?
A potentially modifiable target for improving outcomes in patients with lupus.